课题基金 / 基金详情

Task X7: Preparedness for Testing Zika Virus Vaccines

Task X7: Preparedness for Testing Zika Virus Vaccines
任务 X7：测试寨卡病毒疫苗的准备工作
批准号：
9201105
负责人：
MARY BRUCE
金额：
$232.82万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-09-23 至 2018-09-22
来源：
https://reporter.nih.gov/project-details/9201105
关键词：
BioterrorismClinicalCommunicable DiseasesContractsDevelopmentDrug resistanceEmerging Communicable DiseasesFeasibility StudiesPhaseReadinessSamplingServicesTestingToxicity TestsVaccinesZika Virusassay developmentefficacy testingevaluation/testingimmunogenicitynovel vaccinespathogenproduct developmentsafety testing

项目摘要

项目成果

MARY BRUCE的其他基金

相似基金

相关文献

中文摘要
翻译
传染病疫苗和其他生物制品评估和测试服务(ETS)合同提供从早期可行性研究到I/II阶段材料生产的各种产品开发服务，包括分析开发、免疫原性和有效性测试、临床和非临床样本测试以及安全和毒性测试。这些服务将促进开发和引入新的疫苗和生物制品，以应对生物恐怖主义、抗药性病原体以及新出现和重新出现的传染病的潜在病原体。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task X14: Evaluation of Ebola Vaccines
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing
Task X12: Evaluation of Human Tissue Cross-reactivity of Phase I Clinical Trial Serum Samples
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data